369 results on '"Verdoes, Martijn"'
Search Results
2. Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire
3. Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential
4. Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
5. Development of a Versatile Cancer Vaccine Format Targeting Antigen-Presenting Cells Using Proximity-Based Sortase A-Mediated Ligation of T‑Cell Epitopes.
6. A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
7. Correction to: Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents Iris
8. Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents
9. pH and ROS Responsiveness of Polymersome Nanovaccines for Antigen and Adjuvant Codelivery: An In Vitro and In Vivo Comparison
10. An efficient synthesis of a 6″-BODIPY-α-Galactosylceramide probe for monitoring α-Galactosylceramide uptake by cells
11. The Phosphoinositide Kinase PIKfyve Promotes Cathepsin-S-Mediated Major Histocompatibility Complex Class II Antigen Presentation
12. Semi‐Flexible Immunobrushes Facilitate Effective and Selective Expansion of Antigen‐Specific T Cells.
13. Semi‐Flexible Immunobrushes Facilitate Effective and Selective Expansion of Antigen‐Specific T Cells
14. Investigating how CSTB affects the activity of cysteine cathepsin in the AD‐DS, EOAD, and human cellular models of trisomy Hsa21
15. Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors
16. Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease – Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B
17. Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis
18. Insights in the host response towards biomaterial-based scaffolds for cancer therapy
19. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
20. Detection of protease activity in cells and animals
21. pH and ROS Responsiveness of Polymersome Nanovaccines for Antigen and Adjuvant Codelivery: An In Vitro and In Vivo Comparison
22. CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells
23. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
24. Detection of Intestinal Cancer by Local, Topical Application of a Quenched Fluorescence Probe for Cysteine Cathepsins
25. Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy
26. Inhibitory prodrug mechanism for cysteine cathepsin-targeted self-controlled drug release
27. Enzyme‐Activatable Chemokine Conjugates for In Vivo Targeting of Tumor‐Associated Macrophages
28. Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
29. Validation of the Proteasome as a Therapeutic Target in Plasmodium Using an Epoxyketone Inhibitor with Parasite-Specific Toxicity
30. Subclassification and Biochemical Analysis of Plant Papain-Like Cysteine Proteases Displays Subfamily-Specific Characteristics
31. A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated Macrophages
32. An Optimized Activity-Based Probe for the Study of Caspase-6 Activation
33. Two-step bioorthogonal activity-based proteasome profiling using copper-free click reagents: A comparative study
34. Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
35. Live Cell Imaging and Profiling of Cysteine Cathepsin Activity Using a Quenched Activity-Based Probe
36. Proteasome Activity Imaging and Profiling Characterizes Bacterial Effector Syringolin A
37. Additional file 1 of Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents
38. Specific Cell-Permeable Inhibitor of Proteasome Trypsin-like Sites Selectively Sensitizes Myeloma Cells to Bortezomib and Carfilzomib
39. Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes
40. Inhibitory Prodrug Approach for Selective Elimination of Immunosuppressive M2 Macrophages
41. Dictating Phenotype, Function, and Fate of Human T Cells with Co‐Stimulatory Antibodies Presented by Filamentous Immune Cell Mimics
42. Colony-Stimulating Factor-1 Receptor and Interleukin-6 Receptor Inhibition Prevents Conversion of cDC2s Into Tumor-Induced DC3s
43. Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors
44. Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots
45. Selective Inhibitor of Proteasome's Caspase-like Sites Sensitizes Cells to Specific Inhibition of Chymotrypsin-like Sites
46. Relative quantification of proteasome activity by activity-based protein profiling and LC-MS/MS
47. Activity-Based Proteasome Profiling in Medicinal Chemistry and Chemical Biology
48. Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots
49. Autophagy regulates long‐term cross‐presentation by murine dendritic cells
50. New approaches for dissecting protease functions to improve probe development and drug discovery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.